Be part of the knowledge.™

CME/CE

Your professional development is critical to the care of your patients. Stay on top of the latest treatments and information with ReachMD's CME activities. Our topics span cardiology, diabetes, oncology, women's health and more. And our CME library is continuously growing, every quarter.

3610

LikeLikedUnlike

661-675 of 964

Biologic Rationale for Targeting HER3 and Role in EGFR Resistance
MinuteCE®
Biologic Rationale for Targeting HER3 and Role in EGFR Resistance
- Pasi Antero Jänne, MD, PhD
  Peer
0.75 program credits
Overcoming EGFR Resistance With HER3-Directed ADCs
MinuteCE®
Overcoming EGFR Resistance With HER3-Directed ADCs
- Helena Yu, MD
  Peer
0.75 program credits
Interprofessional Monitoring and Management of AEs With HER3-Directed ADCs
MinuteCE®
Interprofessional Monitoring and Management of AEs With HER3-Directed ADCs
- Helena Yu, MD
  Peer
- Pasi Antero Jänne, MD, PhD
  Peer
0.75 program credits
MinuteCE®
Incorporating FcRn Inhibitors Into Clinical Practice in Chronic Inflammatory Demyelinating Polyneuropathy
- Jeffrey Allen, MD
  Peer
- Nicholas J. Silvestri, MD
  Peer
1.00 credits 10 episodes
Decoding CIDP: Exploring Common and Atypical Variants
MinuteCE®
Decoding CIDP: Exploring Common and Atypical Variants
- Jeffrey Allen, MD
  Peer
- Nicholas J. Silvestri, MD
  Peer
1.00 program credits
Why Early and Accurate CIDP Diagnosis Matters: The Role of Standardized Tools
MinuteCE®
Why Early and Accurate CIDP Diagnosis Matters: The Role of Standardized Tools
- Jeffrey Allen, MD
  Peer
- Nicholas J. Silvestri, MD
  Peer
1.00 program credits
advertisement
Pinpointing CIDP: Diagnosis Challenges and Misdiagnosis/Delayed Diagnosis of CIDP
MinuteCE®
Pinpointing CIDP: Diagnosis Challenges and Misdiagnosis/Delayed Diagnosis of CIDP
- Jeffrey Allen, MD
  Peer
- Nicholas J. Silvestri, MD
  Peer
1.00 program credits
Autoantibodies in CIDP: Prevalence and Diagnostic Implications
MinuteCE®
Autoantibodies in CIDP: Prevalence and Diagnostic Implications
- Jeffrey Allen, MD
  Peer
- Nicholas J. Silvestri, MD
  Peer
1.00 program credits
Navigating CIDP Treatments: IVIg and Steroid Advantages and Limitations
MinuteCE®
Navigating CIDP Treatments: IVIg and Steroid Advantages and Limitations
- Jeffrey Allen, MD
  Peer
- Nicholas J. Silvestri, MD
  Peer
1.00 program credits
CIDP Monitoring Challenges: Suboptimal Responses in CIDP Treatment
MinuteCE®
CIDP Monitoring Challenges: Suboptimal Responses in CIDP Treatment
- Jeffrey Allen, MD
  Peer
- Nicholas J. Silvestri, MD
  Peer
1.00 program credits
Implementing CIDP Clinical Guidelines: Optimizing Therapy
MinuteCE®
Implementing CIDP Clinical Guidelines: Optimizing Therapy
- Nicholas J. Silvestri, MD
  Peer
- Jeffrey Allen, MD
  Peer
1.00 program credits
Novel Mechanisms of Action: FcRn Inhibitors
MinuteCE®
Novel Mechanisms of Action: FcRn Inhibitors
- Jeffrey Allen, MD
  Peer
- Nicholas J. Silvestri, MD
  Peer
1.00 program credits
advertisement
Clinical Benefits of FcRn Inhibitors: Innovations in CIDP Management and Treatment
MinuteCE®
Clinical Benefits of FcRn Inhibitors: Innovations in CIDP Management and Treatment
- Nicholas J. Silvestri, MD
  Peer
- Jeffrey Allen, MD
  Peer
1.00 program credits
Comprehensive CIDP Care: The Role of Multidisciplinary Teams and Patient-Reported Outcomes
MinuteCE®
Comprehensive CIDP Care: The Role of Multidisciplinary Teams and Patient-Reported Outcomes
- Jeffrey Allen, MD
  Peer
- Nicholas J. Silvestri, MD
  Peer
1.00 program credits
Finally, I Can Take a Break from My Itch! Optimizing CKD-aP Treatment
CME/CE
Finally, I Can Take a Break from My Itch! Optimizing CKD-aP Treatment
- Jörg Latus, MD
  Peer
0.25 credits

Program Chapters

Segment Chapters

Playlist:

Recommended